Ronald L. Merriman

Inhibition of protein kinase C by calphostin C is light-dependent

Robert F. Bruns, Freeman D. Miller, Ronald L. Merriman et al. · Biochemical and Biophysical Research Communications · 1991 · 369 citations

Life Sciences, Biochemistry, Molecular Biology +8

Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T1/2 clone 8 cells.

Ronald L. Merriman, John S. Bertram · PubMed · 1979 · 151 citations

Medicine, Oncology, Pharmacology +11

In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.

Richard M. Schultz, Ronald L. Merriman, Sherri L. Andis et al. · PubMed · 1995 · 113 citations

Medicine, Oncology, Pharmacology +12

Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models

Ronald L. Merriman, Larry W. Hertel, Richard M. Schultz et al. · Investigational New Drugs · 1996 · 80 citations

Medicine, Oncology, Pharmacology +8

2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase)

Joseph S. Warmus, Cathlin Flamme, Lu Yan Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 67 citations

Medicine, Medicinal Chemistry, Pharmacology +9